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(57) ABSTRACT 
A segmented endograft includes at least one positioning 
segment and at least one main body segment which are 
separately deployable. The at least one positioning segment 
and at least one main body segment may be connected one 
to another. For example, the at least one positioning segment 
and at least one main body segment may be connected along 
a portion of a circumference thereof, but unconnected along 
a remainder of the circumference thereof. The at least one 
positioning segment overlaps a portion of the at least one 
main body segment. Deployment systems may include the 
segmented endograft and the segmented endograft may be 
deployed according to various methods. 
10 Claims, 4 Drawing Sheets 
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GRAFT WITHIN A GRAFT ENDOLUMINAL 
GRAFT 
This application claims the benefit of priority in U.S. 
Provisional Patent Application Ser. No. 61/487,050, filed on 
May 17, 2011, the entirety of which is incorporated herein 
by reference. 
TECHNICAL FIELD 
The present disclosure relates generally to endoluminal 
grafts. More particularly, the disclosure relates to endolu-
minal grafts including at least one separately deployable 
portion facilitating remote positioning and repositioning of 
the device within the lumen of a blood vessel. 
BACKGROUND OF THE INVENTION 
It is known to provide endoluminal grafts or endografts 
for treating vascular lesions or pathologies such as aneu-
rysms, stenosis, dissections, and others using minimally 
invasive surgical techniques. A conventional endograft is 
typically radially compressed or constrained, mounted on a 
deployment catheter, introduced into the vasculature, and 
advanced to its intended deployment site. Such conventional 
endografts, as is known in the art, typically include a metal 
lattice element (stent) which provides an expansile force and 
a fabric (graft) designed to contain pressurized bloodflow 
within its lumen, thereby excluding bloodflow from the site 
of the vascular pathology or lesion. As is known, the stent 
and graft portion of the endograft are typically attached one 
to the other or incorporated one with the other, leading to the 
common nomenclature "stent graft." Suitable materials for 
fabricating such endografts are well known in the art. 
Typically, endografts are introduced into the vasculature 
from a location remote from the intended treatment zone, for 
example a femoral artery. The endograft must then be 
positioned and deployed so with the graft proximal and 
distal ends bracketing the vascular lesion, further whereby 
each graft end is positioned in a healthy portion of the blood 
vessel being treated, to provide an occlusive seal. This 
allows exclusion of the systemic blood pressure from the 
diseased blood vessel segment. Inaccurate placement of an 
endograft can result in ischemic complications from unin-
tended coverage of branch vessels, or incomplete exclusion 
of the pathology being treated because of minimal apposi-
tion of the endograft and the vessel wall in the sealing zone. 
Further complicating the issue, the intervening healthy 
"landing zone" between the vascular pathology and poten-
tially important branch blood vessels is often very short. 
2 
significant patient risk. Another strategy considered is par-
tially constraining the endograft longitudinally during 
deployment. However, a single piece endograft that is par-
tially constrained longitudinally is still significantly 
5 detached from its deployment catheter, limiting the reposi-
tioning force that can be applied to the graft by manipulation 
of its deployment catheter at the remote introduction site. 
There has accordingly been identified a need in the art for 
an endoluminal graft which, while effective for its intended 
10 purpose, provides additional advantages in allowing repo-
sitioning during placement in a diseased blood vessel, to 
ensure the best positioning of the device to isolate the 
vascular pathology being treated. 
15 SUMMARY OF THE INVENTION 
In accordance with the foregoing need identified in the art 
as described herein, an endoluminal graft or endograft is 
20 provided. The disclosed endograft includes at least one 
separately deployable portion for remote positioning and 
repositioning of the device within the lumen of a blood 
vessel. Advantageously, this feature facilitates the position-
ing, repositioning, and deployment of the device at a site of 
25 a lesion or pathology in a body lumen, for example vascular 
aneurysms, stenosis, dissections, and the like. 
In one aspect, the disclosure relates to a segmented 
endograft including at least one positioning segment and at 
least one main body segment, each being separately deploy-
30 able. The at least one positioning segment and the at least 
one main body segment are partially connected one to the 
other, typically along a portion of a circumference thereof, 
but are separate one from the other along a remainder of the 
circumference. An overlap is defined between adjoining 
35 portions of the at least one positioning segment and the at 
least one main body segment. 
In the following description there are shown and 
described several different embodiments of this invention, 
simply by way of illustration of some of the modes best 
40 suited to carry out the invention. As it will be realized, the 
invention is capable of other different embodiments and its 
several details are capable of modification in various, obvi-
ous aspects all without departing from the invention. 
Accordingly, the drawings and descriptions will be regarded 
45 as illustrative in nature and not as restrictive. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The accompanying drawings incorporated herein and 
50 forming a part of the specification, illustrate several aspects 
of the present invention and together with the description 
serve to explain certain principles of the invention. In the 
drawings: 
In cases such as minimal "landing zones" for proper 
placement of an endograft, the ability to re-position the 
device prior to final placement can improve accuracy and 
greatly improve the odds of safe and effective exclusion of 
the diseased vascular segments. However, during deploy- 55 
ment, endografts are subjected to the displacement forces of 
the pressurized bloodflow in the vessel being treated, cre-
ating a "windsock" effect. Such displacement forces con-
tinue until the endograft is fully deployed or opened and 
blood flow is established through the endograft lumen. For 60 
conventional single piece endografts, however, at that point 
the endograft has been disconnected from the positioning 
device (such as a deployment catheter) and cannot be 
repositioned. 
FIGS. la and lb show a fully constrained segmented 
endograft according to the present disclosure in perspective 
and side cross-sectional view; 
FIGS. 2a and 2b show the endograft of FIG. 1, with a 
positioning segment deployed, with FIG. 2a showing the 
deployed positioning segment in perspective view, and FIG. 
2b showing the deployed positioning segment in a side 
cross-sectional view; 
FIGS. 3a and 3b show the endograft of FIG. 1 fully 
deployed, with FIG. 3a showing a perspective view and FIG. 
3b showing a side cross-sectional view; and 
Strategies have been proposed for overcoming this prob- 65 
!em. These include temporarily arresting bloodflow (for 
example by arresting the heart). However, this poses a 
FIGS. 4a through 4c depict placement and deployment of 
the endograft of FIG. 1 to isolate a lesion such as a vascular 
aneurysm. 
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Reference will now be made in detail to the present 
preferred embodiments of the invention, examples of which 
are illustrated in the accompanying drawings. 
DETAILED DESCRIPTION OF THE 
INVENTION 
In accordance with the foregoing need identified in the art 
4 
assembled deployment catheter/endograft 10 may be 
advanced to the site of the lesion or pathology by sliding the 
assembly over the guidewire. Alternatively, the endograft 10 
may be delivered and deployed by a balloon dilation catheter 
5 as is known in the art, Of course, it is contemplated to 
monitor each step of delivery and deployment, such as by 
known means including without limitation radiography, 
x-ray fluoroscopy, intravascular ultrasound, and the like, to 
as described herein, an endoluminal graft or endograft is 
provided. The disclosed endograft includes at least one 10 
separately deployable portion for remote positioning and 
repositioning of the device within the lumen of a blood 
vessel. Advantageously, this feature facilitates the position-
ing, repositioning, and deployment of the device at a site of 
confirm proper placement. 
On reaching the site of a body lumen lesion or pathology 
such as an aneurysm 26 in a wall of a blood vessel 28 (see 
FIGS. 4a-4c), the endograft 10 is advanced until at least the 
positioning segment 12 is positioned distally to the lesion or 
pathology relative to the site at which the guidewire and 
a lesion or pathology in a body lumen, for example vascular 
aneurysms, stenosis, dissections, and the like. 
In one aspect, a segmented endograft 10 is provided. As 
shown in FIGS. la and lb, the endograft 10 includes at least 
one positioning segment 12 and at least one main body 14, 
with positioning segment 12 defining an overlap 16 at 
adjoining portions of the two segments. The endograft 10 
may be fabricated of overlapping or integrated stent mate-
rials 18 and graft materials 20 (see FIG. lb), as is well 
known in the art, wherein the stent material 18 comprises a 
metal (or other suitable material) lattice structure which 
provides the expansile force when the endograft is deployed. 
In turn, the graft material 20 contains pressurized blood flow 
within a lumen 22 thereof, thereby isolating that blood flow 
from a diseased body lumen section. 
In an embodiment (see especially FIG. lb), positioning 
segment 12 and main body segment 14 may include inte-
grated stent materials 18 and graft materials 20, but overlap 
16 may be fabricated to include only graft materials 20. Any 
suitable material or combination of materials for use as stent 
and graft material, respectively, are contemplated. Lumen 22 
also receives a deployment catheter (not shown) of known 
configuration for delivering the endograft 10 to a site of a 
body lumen lesion or pathology. In turn, as is also known in 
the art, the deployment catheter will likewise define a central 
lumen for receiving a guidewire of known design and 
material, for use in guiding the deployment catheter and 
associated endograft 10 to the site of the body lumen lesion 
or pathology. Of course, other methods of delivery of an 
endograft 10 are known, for example a dilation catheter (not 
shown) of known design. 
The positioning segment 12 and the main body segment 
14 of the endograft 10 are partially connected at adjoining 
portions thereof, such as at attachment 24 (best seen in 
FIGS. 2 and 3). As best seen in FIGS. 2a and 2b, this may 
be accomplished by attaching a portion of an exterior 
circumference of a distal end of main body segment 14 to an 
interior lumen 22 of positioning segment 12. In that fashion, 
positioning segment 12 and main body segment 14 are 
connected one to the other along a portion of a circumfer-
ence thereof, but remain unconnected along the remainder of 
their circumferences. 
15 deployment catheter were introduced. Then, the positioning 
segment 12 and overlap 16 are deployed (see FIGS. 2a, 2b, 
and 4b). Any suitable methods of deployment are contem-
plated to deploy/expand positioning segment 12. For 
example, use of one or more balloons of a balloon dilation 
20 catheter of known design is contemplated, and also use of 
self-expanding stent scaffold configurations (zig-zag stents, 
etc.) or shape memory alloys. Again, proper initial place-
ment of the positioning segment 12 of endograft 10 may be 
monitored by any suitable means including visually, such as 
25 by radiography and the like. 
The skilled artisan will appreciate that positioning seg-
ment 12, once deployed against the wall 28 of the body 
lumen, will assist in keeping the endograft 10 in place but 
since less surface area of the endograft 10 is in contact with 
30 an interior surface of the body lumen, will also facilitate any 
repositioning of the endograft 10 which may be required for 
optimal placement. In turn, the deployed positioning seg-
ment 12 also will allow blood flow through the lumen 22 
thereof, thereby minimizing displacement of the device by 
35 pressurized blood flow and further facilitating repositioning 
of the endograft 10 as needed (with concurrent monitoring) 
to ensure optimal placement of the endograft 10 over the 
lesion or pathology. Because positioning segment 12 is 
connected to main body segment 14 via attachment 24, the 
40 two segments remain coupled allowing more efficient 
manipulation from the remote introduction site via the 
deployment catheter or dilation catheter, and also applica-
tion of greater force in repositioning the device with less 
concomitant concern about damage to the body lumen 
45 interior such as would be expected from a fully deployed 
conventional endograft. 
Further, the endograft 10 may be remotely positioned and 
repositioned as needed for optimal placement according to 
the positioning, size, etc. of the lesion or pathology, the 
50 proximity of the lesion or pathology to vascular branching, 
etc. using the deployment catheter or balloon dilation cath-
eter, which remains encased in the constrained main body 
segment 14. In contrast, a conventional endograft, once 
deployed, can no longer be manipulated using an associated 
55 deployment catheter or the like, in that the lumen of the 
endograft is enlarged and no longer in contact with the 
catheter. As such, any manipulation of a conventional 
endograft for repositioning same can only be done by 
manipulating the endograft itself, which is inherently less 
In use, the endograft 10 may be delivered to a site of a 
body lumen lesion or pathology (see FIGS. 4a-4c) by 
methods well known in the art. For example, the constrained 
endograft 10 may receive a deployment catheter or balloon 
dilation catheter in lumen 22 thereof. As discussed above, 
the deployment catheter or balloon dilation catheter will 
typically include a central lumen for receiving a guidewire 
therein. The guidewire may be introduced into the body 
from a remote site, for example a femoral artery, and 65 
advanced to the site of the lesion or pathology via one or 
more body lumens, for example via vasculature. Next, the 
60 efficient. 
On verification of proper placement, main body 14 is 
deployed (see FIGS. 3a and 3b) by any suitable method as 
was described for positioning segment 12, i.e. balloons, 
self-expanding stent material, shape memory alloy stent 
material, etc. For example, the balloon used to deploy 
positioning segment 12 may be repositioned to deploy main 
body segment 14, or a second balloon may be used. As best 
US 10,335,296 B2 
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shown in FIGS. 3a and 3b, on deployment an exterior 
surface of main body 14 contacts an interior surface of 
overlap 16, thereby forming a tight seal to prevent leakage 
of fluid passing through lumen 22. In tum, exterior surfaces 
of positioning segment 12, overlap 16, and main body 14 5 
then contact interior surfaces of the wall 28 of the body 
lumen being repaired, enlarged, etc. 
The deployed endograft 10 may optionally then be further 
enlarged, such as by a larger balloon, to provide additional 
contact with the body lumen wall 28 interior and to anchor 10 
proximal and distal ends of the endograft 10 above and 
below the body lumen lesion or pathology, in contact with 
healthy body lumen tissue, to provide the desired occlusive 
seal and to isolate the lesion or pathology from blood flow. 
Similar techniques may be employed as are known in the art 15 
when the desired effect is also to enlarge a body lumen such 
as that of a blood vessel, for example to relieve stenoses. Of 
course, other methods for anchoring the deployed endograft 
10 to the wall 28 of the body lumen are known and 
contemplated for use herein, such as providing barbs (not 20 
shown) protruding from the stent material 18 which engage 
the wall 28. 
6 
at least one main body segment having a main body 
segment wall and including a second cylindrical sec-
tion; 
wherein the first cylindrical section of the at least one 
positioning segment and the second cylindrical section 
of the at least one main body segment overlap one 
another along an entire length of both of the first 
cylindrical section and the second cylindrical section 
along a longitudinal axis of the segmented endograft 
and are fixedly attached to one another at only a portion 
of each of a circumference of the first cylindrical 
section and a circumference of the second cylindrical 
section, but are not attached to one another at a remain-
der of each of the circumference of the first cylindrical 
section and the circumference of the second cylindrical 
section; 
wherein the at least one positioning segment is indepen-
dently deployable with respect to the at least one main 
body segment; and 
further wherein on deployment of both the at least one 
positioning segment and the at least one main body 
segment, the at least one positioning segment and the at 
least one main body segment define a fluid-impervious 
lumen passing through the at least one positioning 
segment and the at least one main body segment. 
2. The segmented endograft of claim 1, wherein the at 
least one positioning segment and the at least one main body 
segment each comprise at least one stent material and at least 
one graft material, and the overlap comprises only at least 
30 one graft material. 
It will be appreciated that the present endograft 10 pro-
vides significant advantages compared to conventional one-
piece endoluminal grafts. The multi-segmented configura- 25 
tion, with separately deployable portions, facilitates remote 
positioning and repositioning of the device, ensuring the 
most accurate placement for isolation or exclusion of dis-
eased body lumen tissue. Deployment of only a portion of 
the endograft 10 during such repositioning minimizes dis-
placement of the device by pressurized bloodflow and also 
maintains physical coupling of the undeployed portion of the 
endograft to, e.g., a guidewire to allow manipulation of the 
endograft at areas of body lumen angulation. In tum, the 
need to resort to conventional strategies for eliminating or 
reducing displacement of the device by bloodflow during 
such repositioning, such as temporarily arresting blood flow, 
longitudinal constraint of the endograft during deployment, 
etc., is obviated. 
3. The segmented endograft of claim 1, wherein the main 
body segment wall is disposed at least partially within the 
positioning segment wall. 
4. The segmented endograft of claim 1, wherein on 
35 independent deployment of the at least one positioning 
segment, the at least one positioning segment and the at least 
one main body segment do not define the fluid-impervious 
lumen until independent deployment of the at least one main 
The foregoing description of preferred embodiments has 40 
been presented for purposes of illustration and description. 
It is not intended to be exhaustive or limiting to the invention 
to the precise forms disclosed. Obvious modifications or 
variations are possible in light of the above teachings. For 
example, the depicted embodiments show a substantially 45 
tubular or cylindrical endograft 10, but it is also known in 
the art to provide such devices in a bifurcated or branched 
configuration, as a tapered structure, etc. in tum, additional 
deployable endograft 10 segments may be provided if nec-
essary or desirable according to the size and positioning 50 
(relative to other body lumens) of the body lumen lesion or 
pathology. 
The embodiments were chosen and described to provide 
the best illustration of the principles described herein and 
their practical application to thereby enable one of ordinary 55 
skill in the art to utilize the invention in various embodi-
ments and with various modifications as are suited to the 
particular use contemplated. All such modifications and 
variations are within the scope of the invention as deter-
mined by the appended claims when interpreted in accor- 60 
dance with the breadth to which they are fairly, legally and 
equitably entitled. 
What is claimed is: 
1. A segmented endograft, comprising: 
at least one positioning segment defined by a positioning 65 
segment wall and including a first cylindrical section; 
and 
body segment. 
5. An endograft delivery system, comprising: 
a segmented endograft comprising at least one positioning 
segment defined by a positioning segment wall, said 
positioning segment wall including a first cylindrical 
portion, and at least one main body segment defined by 
a main body segment wall, said main body segment 
wall including a second cylindrical portion; 
a deployment catheter configured to carry the endograft 
and to be endoluminally advanced through a body 
lumen from a remote introduction site to a site of a 
body lumen lesion or pathology; and 
a guidewire for guiding the deployment catheter; 
wherein the first cylindrical portion of the at least one 
positioning segment and the second cylindrical portion 
of the at least one main body segment overlap one 
another along an entire longitudinal length of each of 
the first and second cylindrical portions and are fixedly 
attached to one another at only a portion of the first 
cylindrical portion and the second cylindrical portion, 
but are not attached to one another at a remainder of 
each of the first cylindrical portion and the second 
cylindrical portion; 
wherein the at least one positioning segment is indepen-
dently deployable with respect to the at least one main 
body segment; and 
further wherein only upon deployment of both the at least 
one positioning segment and the at least one main body 
segment, the at least one positioning segment and the at 
US 10,335,296 B2 
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least one main body segment define a tight seal ther-
ebetween, and wherein upon deployment of only the at 
least one positioning segment and not the at least one 
main body segment, said tight seal is not present. 
6. The endograft delivery system of claim 5, wherein the 5 
at least one positioning segment and the at least one main 
body segment each comprise at least one stent material and 
at least one graft material, and the overlap comprises only at 
least one graft material. 
7. The endograft delivery system of claim 5, wherein the 10 
main body segment wall is disposed at least partially within 
the positioning segment wall. 
8. A method for deploying a segmented endograft, com-
prising: 
providing a segmented endograft, the segmented 15 
endograft comprising: 
at least one positioning segment defined by a position-
ing segment wall and including a first cylindrical 
section; and 
at least one main body segment having a main body 20 
segment wall and including a second cylindrical 
section; 
8 
further wherein on deployment of both the at least one 
positioning segment and the at least one main body 
segment, the at least one positioning segment and the 
at least one main body segment define a fluid-
impervious lumen passing through the at least one 
positioning segment and the at least one main body 
segment; 
delivering the segmented endograft in an undeployed state 
from a remote introduction site to a site of a body 
lumen lesion or pathology; 
deploying the at least one positioning segment of the 
segmented endograft independent of the at least one 
main body segment at a site distal to the body lumen 
lesion or pathology relative to the introduction site; 
repositioning the segmented endograft as needed whereby 
a distal and a proximal end of the segmented endograft 
contact healthy body lumen tissue above and below the 
body lumen lesion or pathology; and 
deploying the at least one main body segment of the 
segmented endograft whereby the at least one position-
ing segment and the at least one main body segment 
define the fluid-impervious lumen passing through the 
at least one positioning segment and the at least one 
main body segment, to provide an occlusive seal of the 
body lumen whereby the body lumen lesion or pathol-
ogy is isolated from a flow of blood. 
9. The method of claim 8, wherein the steps of delivering 
the segmented endograft to the site of the body lumen lesion 
or patholo?~' d~ploying the at least one positioning segment, 
and repos1t10mng the segmented endograft are monitored 
visually to confirm a proper deployment of the segmented 
endograft. 
wherein the first cylindrical section of the at least one 
positioning segment and the second cylindrical sec-
tion of the at least one main body segment overlap 25 
one another along an entire length of both of the first 
cylindrical section and the second cylindrical section 
along a longitudinal axis of the segmented endograft 
and are fixedly attached to one another at only a 
portion of each of a circumference of the first cylin- 30 
drical section and a circumference of the second 
cylindrical section, but are not attached to one 
another at a remainder of each of the circumference 10. The method of claim 9, wherein the at least one positioning segment and the at least one main body segment 
35 each comprise at least one stent material and at least one 
graft material, and the overlap comprises only at least one 
graft material. 
of the first cylindrical section and the circumference 
of the second cylindrical section; 
wherein the at least one positioning segment is inde-
pendently deployable with respect to the at least one 
main body segment; and * * * * * 
